ALT
USDAltimmune Inc. Common Stock
$4.110+0.190 (4.847%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$3.920
High
$4.160
Low
$3.775
Volume
2.59M
Company Fundamentals
Market Cap
428.8M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.84M
Exchange
NGM
Currency
USD
52-Week Range
Low $2.9Current $4.110High $11.16
Related News
GlobeNewswire
Altimmune Announces Early Completion of Enrollment in RECLAIM Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder
Enrollment completed ahead of schedule, underscoring strong interest from patient community in a potential new therapeutic option On track to complete the 24-week treatment period and announce topline results in 2026
View more
Reuters
Metsera the US obesity biotech at centre of Novo, Pfizer bidding war
Metsera has become the obesity drug market's hottest ticket.
View more
GlobeNewswire
Altimmune to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025
GAITHERSBURG, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ:ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases,
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.